Results 181 to 190 of about 113,305 (364)

Deep Brain Stimulation in a Child with Aicardi‐Goutières Syndrome‐7 (AGS7): A Case Report and Literature Review

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan   +10 more
wiley   +1 more source

Characteristics and Causes of Stillbirths Following Disruption to Antenatal Care During Implementation of COVID‐19 Mitigation Measures

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background and Aim Restrictions to mitigate COVID‐19 transmission during the pandemic led to the disruption of routine antenatal care. We aimed to assess if those disruptions impacted the rates and types of stillbirths that occurred during that time.
Jasmine Donaghey   +6 more
wiley   +1 more source

Glycochenodeoxycholate-Induced Apoptosis Is Not Reduced by Augmenter of Liver Regeneration in the Human Hepatoma Cell Line HuH-7 [PDF]

open access: yes, 2010
Denk, Gerald Ulrich   +5 more
core   +1 more source

Novel mutation in CCBE 1 as a cause of recurrent hydrops fetalis from Hennekam lymphangiectasia-lymphedema syndrome-1. [PDF]

open access: yes, 2018
Whole exome sequencing (WES) was used to determine the etiology of recurrent hydrops fetalis in this case of Hennekam lymphangiectasia-lymphedema syndrome-1.
Andreasen, Tara S   +7 more
core  

Hypothermic Oxygenated Machine Perfusion (HOPE) During Total Vascular Exclusion With Veno‐Venous Bypass for Giant Hepatic Hemangioma Resection

open access: yesArtificial Organs, EarlyView.
Hypothermic oxygenated machine perfusion (HOPE) during total vascular exclusion with veno‐venous bypass for major hepatic resection is a safe procedure and could help to reduce ischemia–reperfusion lesions and related complications.
Mehdi Boubaddi   +7 more
wiley   +1 more source

Idiopathic Recurrent Cholestasis

open access: bronze, 1967
G. M. Stathers, C. Reed, E. Hirst
openalex   +1 more source

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy